Category Archives: MS Treatment

Isaac Saunders-Rennards may need to travel to Germany for proton beam therapy THE family of a three-year-old boy have been told they must raise 70,000 to pay for his cancer treatment. Continue reading →

Since emigrating from Syria at the age of five, I have personally experienced the uphill battle of obtaining health care coverage as a non-US citizen. My family, along with many other immigrant and low-income families, are often forced to choose between receiving care and prescription medicines or paying a stream of medical bills Continue reading →

Newswise October 5, 2020(BRONX, N.Y) Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert Einstein College of Medicine and Montefiore Health System, has received two grants from the National Institutes of Health totaling $13.8 million to conduct studies on pre-dementia and Alzheimers disease. Continue reading →

Gilenya (fingolimod) and Tecfidera (dimethyl fumarate) are similarly effective at lowering the frequency of relapses and delaying disability progression in people with relapsing-remitting multiple sclerosis (RRMS), a real-world study from Switzerland reported. Continue reading →

A drug which has already been approved for the treatment of multiple sclerosis (MS) patients effectively inhibits the coronavirus when tested on human lung cells and, at the same time, fights the immune reaction that is killing COVID-19 patients around the world. In a new study, biomedicine researchers at the Aarhus University (Aarhus, Denmark) have shown that a drug called dimethyl fumarate (DMF), which is approved for the treatment of MS patients, inhibits the growth of a range of viruses in the bodys cells and that this includes the coronavirus (SARS-CoV2) at least when the researchers test it in a test tube. When the pandemic struck, the biomedicine researchers were in the process of testing the effects of a drug which was virtually identical with a particular sclerosis medicine, namely a substance called 4-octyl-itaconate, which is used on e.g. Continue reading →

Roche is focused on finding new treatments and diagnostics that help patients live longer, better lives, and evolve the practice of medicine. By Andrew Humphreys [emailprotected] F. Continue reading →

By Ashley Lyles October 8, 2020 The Science Explained Article In Brief Selective serotonin reuptake inhibitor use following intracerebral hemorrhage was associated with fewer depressive symptoms and an increased risk of recurrent hemorrhagic stroke. Patients treated with selective serotonin reuptake inhibitors (SSRIs) for post-stroke depression following intracerebral hemorrhage (ICH) had fewer depressive symptoms but also have an increased risk of recurrent hemorrhagic stroke, according to a longitudinal cohort study published online on August 31 in JAMA Neurology. SSRIs are generally considered first-line therapies for depression after stroke, the study authors noted, but they are also known to be associated with first-ever ICH risk Continue reading →

Research Nester Market Research Consulting & Industry reports According to Research Nester, Multiple Sclerosis Drugs and Treatment Market in North America region is anticipated to witness largest share in the market on account of presence of highly advanced medical facilities along with large number of research institutions in the region. Multiple Sclerosis Drugs and Treatment Market: Global Demand Analysis & Opportunity Outlook 2027, which delivers detailed overview of the global multiple sclerosis drugs and treatment market in terms of market segmentation by drug, by route of administration, by distribution channel and by region. Further, for thein-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porters five force model Continue reading →

The first grant totals $7.6 million over five years and will fund a study of a pre-dementia condition called motoric cognitive risk syndrome (MCR) in 11,000 older adults living in six countries. Continue reading →

A young Australian woman stranded overseas without the right to work during the coronavirus pandemic was told by her Federal MP to "treat the experience as one of life's big adventures", despite her life savings dwindling and mental health being impacted. Young Sydney woman Chelsea Dorricott, 23, has been stranded in the United Kingdom for months due to the coronavirus pandemic. Continue reading →